estradiol, 25 mcg

DRUG6 trials

Sponsors

Novo Nordisk A/S

Conditions

MenopausePostmenopausal Vaginal AtrophyUrinary Infections

Phase 1

Comparison of Two Vaginal Tablets, Produced at Different Sites, in Postmenopausal Women With Atrophic Vaginitis

CompletedNCT01085877

Novo Nordisk A/SMenopause, Postmenopausal Vaginal Atrophy

Start: 2010-03-31End: 2010-05-31Updated: 2014-06-26

Pharmacokinetic Assessment of the Absorption of Estradiol in Postmenopausal Women With Atrophic Vaginitis

CompletedNCT01486979

Novo Nordisk A/SMenopause, Postmenopausal Vaginal Atrophy

Start: 2007-01-31End: 2007-05-31Updated: 2017-02-08

Phase 3

Evaluation of Safety and Efficacy of 17-Beta Estradiol in Treatment of Atrophic Vaginitis: An Extension Trial

CompletedNCT00464971

Novo Nordisk A/SMenopause, Postmenopausal Vaginal Atrophy

Start: 1995-01-31End: 1996-11-30Target: 102Updated: 2017-03-01

Efficacy and Safety of 17-Beta Estradiol in Treatment of Atrophic Vaginitis

CompletedNCT00465192

Novo Nordisk A/SMenopause, Postmenopausal Vaginal Atrophy

Start: 1994-08-31End: 1995-11-30Target: 230Updated: 2017-03-01

Preventive Effect of Treatment With Estradiol Vaginal Tablets on Recurrent Urinary Tract Infections in Post-menopausal Women

TerminatedNCT00560924

Novo Nordisk A/SMenopause, Urinary Infections

Start: 2003-03-21End: 2004-03-17Updated: 2017-02-28

Unknown Phase

Vagifem® Used for the Treatment of Atrophic Vaginitis Due to Oestrogen Deficiency

CompletedNCT01507454

Novo Nordisk A/SMenopause, Postmenopausal Vaginal Atrophy

Start: 2006-04-30End: 2006-11-30Updated: 2017-02-08

Related Papers

Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial.

2008-01-01114 citations